Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis (Q42551712)

2 November 2017

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis (English)

1 reference

2 November 2017

Guillain–Barré syndrome

0 references

1 reference

1 reference

Campylobacter jejuni

1 reference

1

Yuki N

1 reference

2 November 2017

Taki T

2

1 reference

PubMed ID

8982115

2 November 2017

Handa S

series ordinal

3

1 reference

2 November 2017

1 December 1996

1 reference

Journal of Neuroimmunology

2 November 2017

1 reference

2 November 2017

71

1 reference

2 November 2017

155-161

1 reference

2 November 2017

1-2

1 reference

Serum antibodies to gangliosides in Guillain-Barré syndrome

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

IgM binding to sialosyllactosaminylparagloboside in a patient with polyradiculoneuropathy due to Mycoplasma pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Microscale analysis of glycosphingolipids by TLC blotting/secondary ion mass spectrometry: a novel blood group A-active glycosphingolipid and changes in glycosphingolipid expression in rat mammary tumour cells with different metastatic potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Antibody detection in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2896%2900142-7

7 January 2021

10.1016/S0165-5728(96)00142-7

Identifiers

DOI

1 reference

2 November 2017

1 reference

PubMed ID

8982115